77 related articles for article (PubMed ID: 7942215)
1. [Risk of suffering from a second primary neoplasm in patients with bladder tumor].
Osca García JM; Morera Martínez JF; Catalá Barceló T; Alfonso Gil R; Ruiz Cerdá JL; Martínez Jabaloyas JM; Jiménez Cruz JF
Actas Urol Esp; 1994 Jun; 18(6):646-50. PubMed ID: 7942215
[TBL] [Abstract][Full Text] [Related]
2. [The risk of second primary neoplasm in prostatic cancer patients].
Osca García JM; Morera Martínez JF; Alfonso Gil R; Catalá Barceló T; Ruiz Cerdá JL; Martínez Jabaloyas JF; Jiménez Cruz JF
Actas Urol Esp; 1993 Oct; 17(9):574-8. PubMed ID: 8165938
[TBL] [Abstract][Full Text] [Related]
3. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
4. [Upper urothelium tumor in patients treated with radical cystectomy for transitional carcinoma of the bladder].
Herranz Amo F; Verdú Tartajo F; Díez Cordero JM; Bueno Chomón G; Leal Hernández F; Bielsa Carrillo A
Actas Urol Esp; 1999 Mar; 23(3):214-8. PubMed ID: 10363377
[TBL] [Abstract][Full Text] [Related]
5. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
Thellenberg C; Malmer B; Tavelin B; Grönberg H
J Urol; 2003 Apr; 169(4):1345-8. PubMed ID: 12629357
[TBL] [Abstract][Full Text] [Related]
6. [Superficial and infiltrating bladder tumor. Epidemiologic differences in a study of incident cases].
Fernández Fernández A; Gil Fabra J; Fernández Ruiz M; Otero Mauricio G
Actas Urol Esp; 1994; 18(10):983-5. PubMed ID: 7856490
[TBL] [Abstract][Full Text] [Related]
7. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis.
Wright JL; Hotaling J; Porter MP
J Urol; 2009 Mar; 181(3):1035-9; discussion 1039. PubMed ID: 19150569
[TBL] [Abstract][Full Text] [Related]
8. Higher than expected association of clinical prostate and bladder cancers.
Singh A; Kinoshita Y; Rovito PM; Landas S; Silberstein J; Nsouli I; Wang CY; Haas GP
J Urol; 2005 May; 173(5):1526-9. PubMed ID: 15821472
[TBL] [Abstract][Full Text] [Related]
9. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
Chrouser K; Leibovich B; Bergstralh E; Zincke H; Blute M
J Urol; 2005 Jul; 174(1):107-10; discussion 110-1. PubMed ID: 15947588
[TBL] [Abstract][Full Text] [Related]
10. [Tumors of the superior urinary tract and associated bladder tumors: clinical and etiological aspects].
Bretheau D; Lechevallier E; Jean F; Rampal M; Coulange C
Prog Urol; 1993 Dec; 3(6):979-87. PubMed ID: 8305941
[TBL] [Abstract][Full Text] [Related]
11. [Transitional carcinomas of the urinary tract: synchronous and metachronous lesions].
Arrizabalaga M; Navarro J; Mora M; Castro M; Extramiana J; Mañas A; Diez J; Paniagua P
Actas Urol Esp; 1994 Sep; 18(8):782-96. PubMed ID: 7998507
[TBL] [Abstract][Full Text] [Related]
12. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
[TBL] [Abstract][Full Text] [Related]
14. [Infiltrating bladder tumors associated with upper urinary tract tumors].
Ferrero Doria R; Guzmán Martínez-Valls PL; Morga Egea JP; Navas Pastor J; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Fontana Compiano LO
Actas Urol Esp; 1998 Oct; 22(9):762-5. PubMed ID: 9882813
[TBL] [Abstract][Full Text] [Related]
15. [Secondary neoplasm in patients with bladder carcinoma. A case-control study].
Angulo JC; Hontoria J; Dehaini A; Guil M; Sánchez-Chapado M
Actas Urol Esp; 1996 Sep; 20(8):720-4. PubMed ID: 9019946
[TBL] [Abstract][Full Text] [Related]
16. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
Chuang SC; Hashibe M; Scelo G; Brewster DH; Pukkala E; Friis S; Tracey E; Weiderpass E; Hemminki K; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Dresler CM; Boffetta P; Brennan P
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1543-9. PubMed ID: 18559572
[TBL] [Abstract][Full Text] [Related]
17. Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study.
Gervaz P; Bucher P; Neyroud-Caspar I; Soravia C; Morel P
Dis Colon Rectum; 2005 Feb; 48(2):227-32. PubMed ID: 15711864
[TBL] [Abstract][Full Text] [Related]
18. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
19. Urological implications of concurrent bladder and lung cancer.
Vainrib M; Leibovitch I
Isr Med Assoc J; 2007 Oct; 9(10):732-5. PubMed ID: 17987763
[TBL] [Abstract][Full Text] [Related]
20. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden.
Czene K; Hemminki K
J Urol; 2003 Apr; 169(4):1271-5. PubMed ID: 12629341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
